The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests

Pluripotent stem cell (PSC)-based cell therapies have increased steadily over the past few years, and assessing the risk of tumor formation is a high priority for clinical studies. Current in vivo tumorigenesis studies require several months and depend strongly on the site of grafting. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Emi, Arai, Eri, Hatou, Shin, Sayano, Tomoko, Taniguchi, Hiroko, Negishi, Kazuno, Kanai, Yae, Sato, Yasunori, Okano, Hideyuki, Tsubota, Kazuo, Shimmura, Shigeto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Enabling Technologies for Cell-Based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397653/
https://www.ncbi.nlm.nih.gov/pubmed/35666752
http://dx.doi.org/10.1093/stcltm/szac036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397653/
https://www.ncbi.nlm.nih.gov/pubmed/35666752
http://dx.doi.org/10.1093/stcltm/szac036

Ejemplares similares